HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunize.org logo formerly Immunization Action Coalition (IAC)
IAC Home
|
News & Information

News & Information

IZ
EXPRESS
Stay current! Every week, IZ Express features important immunization developments delivered directly to your email box.
Read Latest Issue
Subscribe Today - it's free!
Official Releases
The latest vaccine licensures, recommendations and resources from official sources
  Advisory Committee on Immunization Practices
  Centers for Disease Control and Prevention
  Food and Drug Administration
>> View All
 
What's New at IAC
Chronological listing of new and revised IAC materials
Handouts
VISs
Web Pages
>> View All
 
Coronavirus (COVID-19) Information from IAC
Featured Resources
BREAKING NEWS
5/19/22
CDC recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series, strengthens its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first 
5/17/22
FDA amends EUA and expands eligibility for Pfizer-BioNTech COVID-19 vaccine booster dose to children 5 through 11 Years 
5/6/22
ACIP updates rabies vaccine recommendations - Use of a modified preexposure prophylaxis vaccination schedule to prevent human rabies, US, 2022 
5/5/22
FDA limits use of Janssen (J&J) vaccine to certain individuals-Fact sheet for Healthcare Providers and Recipients and Caregivers revised 
4/1/22
ACIP recommends universal hepatitis B vaccination in adults aged 19-59 Years, US, 2022
3/29/22
CDC recommends additional boosters for certain Individuals
3/29/22
FDA amends EUA, authorizes an additional presentation of Moderna COVID-19 vaccine for booster vaccination doses, not authorized for primary series doses (dark blue caps with purple border labels)
3/29/22
FDA authorizes second booster dose of Pfizer-BioNTech or the Moderna COVID-19 vaccines for older and immunocompromised individuals
3/18/22
ACIP Recommendation for use of Moderna COVID-19 Vaccine in Adults aged 18 years and older, considerations for extended intervals for primary series doses of mRNA COVID-19 vaccines — US, February 2022 
2/25/22
Use of Ebola Vaccine: Expansion of ACIP Recommendations to include two additional populations, US, 2021.
2/18/22
2022 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older
2/18/22
2022 U.S. Recommended Immunization Schedules for Children and Adolescents Aged 18 Years or Younger
2/4/22
CDC's latest information about Vaccine Information Statements (VIS) currently under development or newly released.
2/4/22
New Vaccine Information Statement (VIS) for pneumococcal conjugate vaccine (PCV13, PCV15, and PCV20) released.
2/4/22
Updated VIS for recombinant zoster (shingles) vaccine released.
1/31/22
FDA approves COVID-19 vaccine Spikevax (Moderna) as a two dose primary series for individuals 18 years and older. The EUA remains in effect for third primary series dose and booster dose.
1/28/22
ACIP updates recommendations for adults on use of 15-Valent Pneumococcal Conjugate Vaccine (Vaxneuvance, Merck) PCV15 and 20-Valent Pneumococcal Conjugate Vaccine (Prevnar 20, Pfizer), US, 2022.
1/21/22
ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022.
1/21/22
ACIP Updated Interim Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 vaccine, US, December 2021.
1/7/22
FDA shortens interval to booster dose of Moderna COVID-19 vaccine to 5 months.
1/5/22
CDC endorses ACIP recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC recommends that all adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
1/4/22
CDC recommends Pfizer-BioNTech booster 5 months after completing primary series. CDC recommends moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of Pfizer-BioNTech COVID-19 vaccine 28 days after their second shot.
1/3/22
FDA amends EUA Pfizer-BioNTech vaccine - expands use of a single booster dose to include 12 through 15 years of age, shortens time to booster dose to at least 5 months, and allows for third primary dose for certain immunocompromised children 5 through 11 years of age.
Calendar of events: conferences and meetings on immunization
 
This page was updated on May 19, 2022.
This page was reviewed on May 19, 2022.
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccination and COVID-19
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IZ EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IZ EXPRESS
Subscribe to IZ Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IZ Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IZ EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunize.org  •  2136 Ford Parkway  •  Suite 5011  •  Saint Paul, Minnesota  •  55116
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.